| scholarly article | Q13442814 |
| P50 | author | Samaresh Sau | Q60961349 |
| P2093 | author name string | Hashem O Alsaab | |
| Arun K Iyer | |||
| Shaimaa Yousef | |||
| P2860 | cites work | Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF | Q24609040 |
| Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment | Q26747551 | ||
| Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 | Q27861047 | ||
| Zebrafish as a disease model for studying human hepatocellular carcinoma | Q28081542 | ||
| Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer | Q28477384 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial | Q29617955 | ||
| Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis | Q29619508 | ||
| Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity | Q30712774 | ||
| Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer | Q30746254 | ||
| The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line | Q33177639 | ||
| Global temporal patterns of pancreatic cancer and association with socioeconomic development | Q33784527 | ||
| Advances in antibody-drug conjugates: A new era of targeted cancer therapy. | Q39382257 | ||
| Asialoglycoprotein receptor promotes cancer metastasis by activating the EGFR-ERK pathway. | Q39484302 | ||
| Molecular docking and inhibition of matrix metalloproteinase-2 by novel difluorinatedbenzylidene curcumin analog | Q39686250 | ||
| Functionalized micelles from block copolymer of polyphosphoester and poly(epsilon-caprolactone) for receptor-mediated drug delivery | Q39994293 | ||
| Relationship between hepatocellular carcinoma and cirrhosis | Q40077062 | ||
| Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor | Q40250428 | ||
| Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes. | Q40624706 | ||
| PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome. | Q41526004 | ||
| A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma. | Q47132952 | ||
| Cancer statistics, 2018. | Q47191906 | ||
| Polyvalent Folate-Dendrimer-Coated Iron Oxide Theranostic Nanoparticles for Simultaneous Magnetic Resonance Imaging and Precise Cancer Cell Targeting. | Q48184123 | ||
| Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment | Q49391681 | ||
| Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship | Q50072085 | ||
| Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines | Q51284365 | ||
| CD44 directed nanomicellar payload delivery platform for selective anticancer effect and tumor specific imaging of triple negative breast cancer | Q52573533 | ||
| Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia. | Q52658028 | ||
| Folic acid conjugated polymeric micelles loaded with a curcumin difluorinated analog for targeting cervical and ovarian cancers | Q52764289 | ||
| Design, synthesis and antiproliferative activity of decarbonyl luotonin analogues. | Q54282308 | ||
| Multidrug resistance gene (MDR-1) expression as a useful prognostic factor in patients with human hepatocellular carcinoma after surgical resection | Q74576168 | ||
| Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine | Q77815020 | ||
| Preparation of N-succinyl-chitosan and its physical-chemical properties as a novel excipient | Q80200005 | ||
| A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy | Q84490725 | ||
| Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: are we there yet? | Q86031683 | ||
| Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages | Q91283016 | ||
| Folate Decorated Nanomicelles Loaded with a Potent Curcumin Analogue for Targeting Retinoblastoma. | Q33850440 | ||
| Hepatocellular carcinoma in the world and the middle East | Q34134967 | ||
| Hepatocellular carcinoma: an epidemiologic view | Q34528348 | ||
| A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. | Q34559241 | ||
| Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. | Q35199549 | ||
| Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges | Q35501246 | ||
| Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery | Q35595042 | ||
| Antitumor activity of sorafenib-incorporated nanoparticles of dextran/poly(dl-lactide-co-glycolide) block copolymer | Q35799514 | ||
| Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? | Q36552819 | ||
| Exploiting the enhanced permeability and retention effect for tumor targeting | Q36578875 | ||
| The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells | Q36619843 | ||
| Strategies for the management of hepatocellular carcinoma | Q36863488 | ||
| Systemic Therapy in Hepatocellular Carcinoma | Q37135733 | ||
| Curcumin Analogue CDF Inhibits Pancreatic Tumor Growth by Switching on Suppressor microRNAs and Attenuating EZH2 Expression | Q37220420 | ||
| Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer | Q37405648 | ||
| Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases | Q37411427 | ||
| Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors | Q37710994 | ||
| Tumor delivery of macromolecular drugs based on the EPR effect | Q37715368 | ||
| The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect | Q37742217 | ||
| The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo | Q38054216 | ||
| Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity | Q38314457 | ||
| New synthetic cluster ligands for galactose/N-acetylgalactosamine-specific lectin of mammalian liver | Q38353559 | ||
| Carbohydrate-based materials for targeted delivery of drugs and genes to the liver | Q38555088 | ||
| Assessment of penetration potential of pH responsive double walled biodegradable nanogels coated with eucalyptus oil for the controlled delivery of 5-fluorouracil: In vitro and ex vivo studies. | Q38711319 | ||
| Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures | Q38748647 | ||
| Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue. | Q38753389 | ||
| Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy | Q38778198 | ||
| Green Synthesis and Characterization of Monodispersed Gold Nanoparticles: Toxicity Study, Delivery of Doxorubicin and Its Bio-Distribution in Mouse Model. | Q38853261 | ||
| Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer | Q38868110 | ||
| Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery. | Q38965075 | ||
| Cationic lipid-conjugated dexamethasone as a selective antitumor agent. | Q38978423 | ||
| Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle. | Q38995380 | ||
| Efficient targeted pDNA/siRNA delivery with folate-low-molecular-weight polyethyleneimine-modified pullulan as non-viral carrier | Q39057766 | ||
| Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach. | Q39305508 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hepatocellular carcinoma | Q1148337 |
| curcumin | Q312266 | ||
| P304 | page(s) | e01071 | |
| P577 | publication date | 2018-12-01 | |
| P1433 | published in | Heliyon | Q27727019 |
| P1476 | title | Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma | |
| P478 | volume | 4 |
| Q101557486 | Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: A state-of-the-art review |
| Q89939081 | Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles |
Search more.